Evidence map›Paper›PMID 20386654›Full record

ReviewInternational journal of molecular sciences2010

Novel neuroprotective strategies in ischemic retinal lesions.

Krisztina Szabadfi, Laszlo Mester, Dora Reglodi, Peter Kiss, Norbert Babai, Boglarka Racz, Krisztina Kovacs, Aliz Szabo, Andrea Tamas, Robert Gabriel and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Protective effects of PACAP in ischemia.The journal of headache and pain · 2018
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Krisztina SzabadfiDepartment of Experimental Zoology and Neurobiology, University of Pecs, H-7624 Pecs, Hungary.
Laszlo MesterDepartment of Biochemistry and Medical Chemistry, University of Pecs, H-7624 Pecs, Hungary.
Dora ReglodiDepartment of Anatomy, University of Pecs, H-7624 Pecs, Hungary.
Peter KissDepartment of Anatomy, University of Pecs, H-7624 Pecs, Hungary.
Norbert BabaiDepartment of Experimental Zoology and Neurobiology, University of Pecs, H-7624 Pecs, Hungary.
Boglarka RaczDepartment of Biochemistry and Medical Chemistry, University of Pecs, H-7624 Pecs, Hungary.
Krisztina KovacsDepartment of Biochemistry and Medical Chemistry, University of Pecs, H-7624 Pecs, Hungary.
Aliz SzaboDepartment of Biochemistry and Medical Chemistry, University of Pecs, H-7624 Pecs, Hungary.
Andrea TamasDepartment of Anatomy, University of Pecs, H-7624 Pecs, Hungary.
Robert GabrielDepartment of Experimental Zoology and Neurobiology, University of Pecs, H-7624 Pecs, Hungary.
Tamas AtlaszDepartment of Experimental Zoology and Neurobiology, University of Pecs, H-7624 Pecs, Hungary.
University of Pecs · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Retinal ischemia can be effectively modeled by permanent bilateral common carotid artery occlusion, which leads to chronic hypoperfusion-induced degeneration in the entire rat retina. The complex pathways leading to retinal cell death offer a complex approach of neuroprotective strategies. In the present review we summarize recent findings with different neuroprotective candidate molecules. We describe the protective effects of intravitreal treatment with: (i) urocortin 2; (ii) a mitochondrial ATP-sensitive K(+) channel opener, diazoxide; (iii) a neurotrophic factor, pituitary adenylate cyclase activating polypeptide; and (iv) a novel poly(ADP-ribose) polymerase inhibitor (HO3089). The retinoprotective effects are demonstrated with morphological description and effects on apoptotic pathways using molecular biological techniques.

Indexed as

AnimalsBenzimidazolesDiazoxideDisease Models, AnimalIschemiaNeuroprotective AgentsPituitary Adenylate Cyclase-Activating PolypeptideRetinal Artery OcclusionUrocortinsBenzimidazolesDiazoxideHO 3089Neuroprotective AgentsPituitary Adenylate Cyclase-Activating PolypeptideUrocortinsBCCAOdiazoxideischemiaPACAPPARP-inhibitorrat retinaretinoprotectionurocortin 2

Identifiers

PMID20386654
PMCPMC2852854
OpenAlexW2049463096

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.